-transparent.png){kind=logo}
Options for antiretroviral therapy in patients infected with HIV continue to expand as new drugs are integrated into treatment regimens. Nucleoside/nucleotide reverse transcriptase inhibitors (Nt/NRTIs) remain the backbone of highly active antiretroviral therapy (HAART). Although this is the oldest class of antiretrovirals, pharmacokinetic and pharmacodynamic properties have been less studied as compare to protease inhibotors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). The aim of this article is to review the current status of clinical pharmacology onf Nt/NRTIs, highlighting the issues with clinical interest. Therefore, implications of intracellular pharmacokinetics on dosing schedule, potential for drug-drug interaction and pharmacodynamics is discussed.
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
January 2007,
Clinical drug investigation,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
September 2004,
Journal of acquired immune deficiency syndromes (1999),
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
March 2004,
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
August 2005,
Journal of acquired immune deficiency syndromes (1999),
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
June 2000,
Clinical therapeutics,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
December 2003,
Antiviral therapy,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
January 2006,
AIDS reviews,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
January 2000,
Reviews in medical virology,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
January 2001,
Clinical pharmacokinetics,
S Bonora, and
A Calcagno, and
D Gonzalez de Requena, and
O Bargiacchi, and
G Di Perri
January 2010,
Antiviral research,
